Modeling the role of macrophages in HIV persistence during antiretroviral therapy

HIV preferentially infects activated CD4+ T cells. Current antiretroviral therapy cannot eradicate the virus. Viral infection of other cells such as macrophages may contribute to viral persistence during antiretroviral therapy. In addition to cell-free virus infection, macrophages can also get infected when engulfing infected CD4+ T cells as innate immune sentinels. How macrophages affect the dynamics of HIV infection remains unclear. In this paper, we develop an HIV model that includes the infection of CD4+ T cells and macrophages via cell-free virus infection and cell-to-cell viral transmission. We derive the basic reproduction number and obtain the local and global stability of the steady states. Sensitivity and viral dynamics simulations show that even when the infection of CD4+ T cells is completely blocked by therapy, virus can still persist and the steady-state viral load is not sensitive to the change of treatment efficacy. Analysis of the relative contributions to viral replication shows that cell-free virus infection leads to the majority of macrophage infection. Viral transmission from infected CD4+ T cells to macrophages during engulfment accounts for a small fraction of the macrophage infection and has a negligible effect on the total viral production. These results suggest that macrophage infection can be a source contributing to HIV persistence during suppressive therapy. Improving drug efficacies in heterogeneous target cells is crucial for achieving HIV eradication in infected individuals.

     

Identification and characterization of microRNAs in phloem and xylem from ramie (Boehmeria nivea)

Molecular Biology Reports - Ramie (Boehmeria nivea) is a widely cropped species in southern China due to its high economic value of natural fiber for industry. Development of phloem and xylem is...     

Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the CDK6/FOXM1 axis

Molecular and Cellular Biochemistry - Population data have consistently demonstrated a correlation between circulating branched-chain amino acids (BCAA) and insulin resistance. Most recently valine...     

Effects of different 2A peptides on transgene expression mediated by tricistronic vectors in transfected CHO cells

Molecular Biology Reports - Multicistronic vectors can increase transgene expression and decrease the imbalance of gene expression in the Chinese hamster ovary (CHO) cell expression system. Small,...     

Activation of PPAR-β/δ Attenuates Brain Injury by Suppressing Inflammation and Apoptosis in a Collagenase-Induced Intracerebral Hemorrhage Mouse Model

Neurochemical Research - Brain injury has been proposed as the major cause of the poor outcomes associated with intracerebral hemorrhage (ICH). Emerging evidence indicates that the nuclear...     

Integrated Bioinformatics Analysis for the Identification of Key Molecules and Pathways in the Hippocampus of Rats After Traumatic Brain Injury

Neurochemical Research - High-throughput and bioinformatics technology have been broadly applied to demonstrate the key molecules involved in traumatic brain injury (TBI), while no study has...     

草地贪夜蛾幼虫在玉米和小麦上的取食和生长发育特性比较

【目的】评估草地贪夜蛾Spodoptera frugiperda转移至小麦上为害和暴发的风险。【方法】采用室内饲养观察与调查统计的方法,测定和比较了23℃下草地贪夜蛾在玉米和小麦上的取食和生长发育特性及种群生命表参数。【结果】草地贪夜蛾在小麦上可以完成世代,其3龄后幼虫取食小麦的取食量及体重指标显著地高于同处理后时间在玉米上取食的;而食物利用效率、幼虫存活率、幼虫发育历期、卵孵化率均显著低于取食玉米的。取食玉米和取食小麦的草地贪夜蛾的平均蛹重、产卵前期、单雌产卵量等指标间无显著差异。另外,生命表参数比较结果表明,取食玉米和取食小麦的草地贪夜蛾的平均世代周期(T)、内禀增长率(r_m)和周限增长率(λ)间均无显著差异,取食玉米的草地贪夜蛾的净增殖率(R_0)为303.55±2.04,显著高于取食小麦的。【结论】草地贪夜蛾取食小麦时,生长发育速度快,能够完成世代生活史,但其食物利用效率、种群繁殖能力等却均低于取食玉米时,说明草地贪夜蛾更适宜在玉米上取食为害,存在转移至小麦为害的风险,但考虑到虫源、自然温度等条件,草地贪夜蛾在小麦上暴发的风险较小。本研究结果为明确草地贪夜蛾在小麦上为害和暴发的风险以及草地贪夜蛾的科学防控提供了理论依据。     

Dahuang Zhechong pill attenuates CCl4-induced rat liver fibrosis via the PI3K-Akt signaling pathway

It is well characterized that activated hepatic stellate cells (HSCs) exert critical functions in accelerating the progression of liver fibrosis. Previous studies have indicated that Dahuang Zhechong pill (DHZCP), a traditional Chinese herbal medicine, is capable of inactivating HSCs and thus attenuate the formation of liver fibrosis in rats. However, pharmacological mechanisms of DHZCP in alleviating liver fibrosis remain unclear. This study aims to investigate the antifibrotic role of DHZCP through inhibiting the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (Akt) pathway. DHZCP was found to significantly suppresses extracellular matrix formation and immune cell infiltration, thus alleviating liver fibrosis symptoms in the in vivo model. Moreover, DHZCP reduced serum levels of transforming growth factor β1 and tumor necrosis factor-α in rats with liver fibrosis. DHZCP treatment remarkably downregulated protein levels of PI3K and phosphorylated Akt, as well as fibrosis markers. In vitro experiments further demonstrated that DHZCP markedly suppressed HSCs proliferation by downregulating PI3K/Akt, which exerted a synergistic effect with the PI3K inhibitor LY294002. To sum up, our results confirmed that DHZCP exerted an antifibrotic effect in the animal model through inactivating the PI3K/Akt pathway, thus protecting rats from liver injury.